Оригинальный русский текст: https://vavilovj-icg.ru/2017-year/21-8/
STRUCTURE AND INTERACTION OF MACROMOLECULES
The threedimensional shape of a DNA molecule is a key property influencing its functional specificity and the nature of its molecular interactions. The characteristic shape into which a DNA molecule folds under certain conditions is a manifestation of its micromechanical and structural features, which are sequencedependent. DNA shaperelated properties can there fore be determined in a predictable manner. A number of models have been designed to describe intrinsic DNA curvature, incorporating a set of helical parameters which can be applied to operative threedimensional reconstruction of the DNA structures. Alternatively, desired base pair parameters can be computed based on publicly available information about atomic DNA structures. Further, taking the base pairs as rigid bodies, their relative location in space can be estimated based on these parameters. Matrices are a common method to implement any rigid body transformations and are widely used in the modeling of DNA structures. Quaternions are the more straightforward and robust alternative for matrices. Unit quaternions can represent only a rotation, whereas dual quaternions combine rotation and translation into a single state. In the present guide, the algebra of unit and dual quaternions is applied for the first time to modeling of the DNA helical path, based on conformational parameters of the base pair steps. Although dual quaternions are preferable for modeling of DNA structure in detail, the use of unit quaternions is sufficient to predict the DNA trajectory and all calculations of DNA shape features. In order to analyze DNA shape and chain sta tistics, and predict the micromechanical properties of DNA molecules based on coordinates of the helical path, the widely used as well as original algorithms for computing DNA curvature, radius of gyration, persistence length and phasing of DNA bends are described. Taken together, these algorithms will be useful both in the in silico analysis of relatively short DNA fragments as well as in topological mapping of whole genomes.
HUMAN AND ANIMAL SYSTEMS BIOLOGY
SYSTEMS BIOLOGY AND BIOMEDICINE
ECOLOGICAL AND POPULATION GENETICS
MAINSTREAM TECHNOLOGIES IN GENETICS AND CELL BIOLOGY
The present work describes the construction of the gene encoding the recombinant protein flagGprotE, its synthesis, purification and study. The recombinant flagGprotE protein is a promising molecule for developing a candidate recombinant vaccine against tickborne encephalitis by the ability to bind to monoclonal antibodies (MCA) against native protein E of tickborne encephalitis virus. The antigenic determinants of two recombinant proteins were studied: protE and flagGprotE using a panel of 8 MCA. The recombinant protein protE comprises the tickborne encephalitis virus envelope protein and the flagGprotE recombinant protein has an additional flagG domain encoding flagellin G of Salmonella typhi. It was found that the MCA tested revealed epitopes on the recombinant protein protE. This indicates that the investigated recombinant protein has an antigenic structure similar to the antigenic structure of the native tickborne encephalitis virus protein E. In the study of the recombinant protein flagGprotE by the ability to bind a panel of 8 MCA, only five of them react with epitopes of the tested protein. MCA 4F6, 7F10, and 6B9 did not recognize the corresponding epitope in the recombinant flagGprotE protein, while in the recombinant protein protE, these epitopes were detected successfully. Our data indicate that the antigenic structure of recombinant protEprotein can be changed under the influence of the flagellin domain, which in turn can lead to the unavailability of some antigenic determinants. This fact must be taken into account when constructing recombinant molecules with antigenic properties. Nevertheless, the fundamentally important regions in the region of the fusion peptide and III domain are antigenically present on the surface of the recombinant protein. This should ensure the formation of neutralizing antibodies, and the presence of a complete amino acid sequence of protein E in the recombinant protein induces the formation of a Tcell immune response. The emergence of a new generation of vaccines against tickborne encephalitis with a higher level of safety and immunogenicity will improve the vaccine prevention of the population from tickborne encephalitis.
Fullyhuman antibodies have a great therapeutic importance; however, the development of stable strains providing a high level of production of fullsize antibodies is a challenging task, as antibody molecules contain two types of polypeptide chains. To develop the producing strain, random integration of the plasmid containing the gene encoding the target protein into the genome of the host cells is commonly used. The aim of this study was the development of an original expression system, using gene targeting to integrate the gene encoding the fullyhuman antibody into the transcriptionally active region of the genome of eukaryotic suspension cells CHOS. To develop a stable strain, the cassette vector plasmid pCDNA5/FRTDHFRCHCL containing the site of homologous recombination and the genes encoding heavy and light chains of the fully human antibody of the IgG1/kappa class was constructed at the first step. Notably, DNA of the plasmid pCDNA5/FRTDHFRCHCL was organized in such a way that the restriction sites for rapid cloning of DNA fragments encoding the variable domains of heavy and light chains were inserted upstream of the sequences encoding constant domains of the heavy and light chains of the antibody. Secondly, DNA fragments encoding the variable domains of the heavy and light chains of antibody against orthopoxvirus protein p35 were inserted into the pCDNA5/FRTDHFRCHCL cassette plasmid. Then, CHOS/FRT cells, which contain the FRTsite for homologous recombination and are able to produce green fluorescence protein GFP, were transfected with the constructed plasmid. After the insertion of the target genes into the FRTsite, GFP production was supposed to stop. Using this selection system, a stable clone producing target antibody fh8E was selected with the level of production of about 100 μg/ml. The binding affinity of purified antibody fh8E with the targeted protein, measured by surface plasmon resonance, was 12 nM. In addition, antibody fh8E demonstrated antivaccinia virus activity in the plaque reduction neutralization test in vitro.